Cargando…
Systemic Immune-Inflammation Index Is Superior to Neutrophil to Lymphocyte Ratio in Prognostic Assessment of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
RESULTS: SII, NLR, and PLR did not define patient groups with distinct clinicopathological characteristics. SII, NLR, and PLR cut-off values were 547, 2.13, and 88.23, as determined by ROC analysis; the corresponding areas under the curve (AUCs) were 0.625, 0.555, and 0.571, respectively. Cox regres...
Autores principales: | Jiang, Cong, Lu, Yubo, Zhang, Shiyuan, Huang, Yuanxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762645/ https://www.ncbi.nlm.nih.gov/pubmed/33381583 http://dx.doi.org/10.1155/2020/7961568 |
Ejemplares similares
-
Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy
por: Jiang, Cong, et al.
Publicado: (2022) -
A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Jiang, Cong, et al.
Publicado: (2022) -
Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer
por: Cong, Rong, et al.
Publicado: (2020) -
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
por: Liontos, M., et al.
Publicado: (2021) -
Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy
por: Jia, Wangqiang, et al.
Publicado: (2021)